T[he]{.smallcaps}formation of vesicles for transport between membrane-bound organelles requires assembly of coat proteins that are recruited from the cytosol. These proteins direct the sequestration and concentration of cargo as well as invagination of the membrane. One of the best studied classes of coats involved in vesicle budding is comprised of clathrin and its adaptor proteins (APs)^1^, AP-1 and AP-2 ([@B49]). In clathrin-mediated vesicle transport the AP complexes play the dual role of cargo selection and recruitment of clathrin to the membrane. These adaptors are heterotetramers containing two large chains (adaptins, α or γ and β), one medium chain (μ), and one small chain (σ). AP-1 (γ, β1, μ1, and σ1) functions in sorting at the TGN, whereas AP-2 (α, β2, μ2, and σ2) is involved in receptor capture at the PM during endocytosis.

Although there is a great deal of evidence supporting the involvement of adaptors in clathrin-mediated vesicle budding, recent studies in animal cells have led to the discovery of a novel adaptor-like complex, AP-3, that seems to function independently of clathrin ([@B28]; [@B53]). AP-3 has identical subunit architecture to AP-1 and AP-2, with two adaptin-like subunits (δ and β3), a medium chain (μ3), and a small chain (σ3) ([@B53], [@B54]; [@B11], [@B12]). AP-3 antibodies label a perinuclear region, perhaps the TGN, and punctate structures extending to the cell periphery, which may be endosomal compartments ([@B53], [@B54]; [@B11]). However, the mammalian AP-3 complex does not colocalize with clathrin or AP-1 and AP-2 adaptors in cells and it does not copurify with brain clathrin-coated vesicles ([@B28]; [@B53], [@B54]; [@B12]). Clues to the function of AP-3 have come from the discovery that the *garnet* gene of *Drosophila* encodes a protein closely related to δ adaptin ([@B34]; [@B54]). Mutations in *garnet* cause decreased pigmentation of the eyes and other tissues and a reduced number of pigment granules, which may be lysosome-like organelles ([@B34]; [@B54]). Thus, AP-3 is proposed to function in clathrin-independent transport between the TGN, endosomes and/or lysosomes, although its exact sorting function is still not known.

Over the last several years, yeast homologues of the mammalian adaptor subunits have been identified, allowing for the examination of specific functions of these proteins in a genetically tractable organism. Genes encoding subunits sufficient for at least three complete AP complexes have been identified by sequence homology ([@B36]; [@B41]; [@B56]) or by function ([@B35]). *APL1-APL6* encode large chain/ adaptin-related subunits, *APM1-APM4* encode μ-like chains, and *APS1-APS3* are genes for σ-related proteins. Apl2p (β), Apl4p (γ), Apm1p (μ1), and Aps1p (σ1) are thought to be subunits of an AP-1--like complex that functions with clathrin at the late Golgi/TGN ([@B36]; [@B41]; [@B56]; Payne, G., personal communication). Mutations in the yeast AP-1 genes enhance the growth and the α-factor processing defects of a temperature sensitive (ts) allele of the clathrin heavy chain gene ([@B36]; [@B41]; [@B56]; Payne, G., personal communication). The latter phenotype is a hallmark of clathrin-deficient yeast, in which late Golgi/ TGN proteins, such as the α-factor processing enzymes Kex2p and dipeptidyl amino peptidase-A (DPAP)-A, are not retained in the late Golgi but escape to the cell surface ([@B51]). To date, no yeast adaptor subunit has been shown to be important for endocytosis, although Apl3p, Apm4p, and Aps2p are most homologous to mammalian AP-2 α, μ2 and σ2, respectively.

Recently, a yeast adaptor related to AP-3 of animal cells was described ([@B35]). It is comprised of Apl5p, Apl6p, Apm3p, and Aps3p, which show preferential homology to mammalian δ, β3, μ3, and σ3, respectively. Mutations in each of these subunits were isolated by their ability to suppress the lethality resulting from loss of function of PM casein kinase 1 encoded by a gene pair, *YCK1* and *YCK2.* Yck activity was found to be required for constitutive endocytosis of the a-factor receptor (Ste3p), and AP-3 subunit mutations partially rescued this internalization defect ([@B35]). However, the AP complex itself is not necessary for endocytosis, nor is it required for sorting of carboxypeptidase Y (CPY) or retention of late Golgi proteins. Furthermore, unlike disruption of the yeast AP-1 complex, loss of AP-3 function causes no synthetic phenotype in combination with *chc1* mutations, suggesting it may function independently of clathrin. Although these data indicated that Apl5p, Apl6p, Apm3p, and Aps3p comprise an AP-3-like adaptor, its precise sorting role was still not known.

In this report we describe a genetic approach to determine the function of the yeast AP-3 complex. A colony sectoring screen was performed to identify genes that are essential in the absence of Apm3p, the yeast AP-3 μ chain. Such synthetic lethal screens can be used to identify functional homologues, genes whose proteins function in intersecting or parallel pathways, and genes whose proteins physically interact ([@B5]). We have cloned the gene for the *ap[m]{.ul}* [t]{.ul}hree [s]{.ul}ynthetic lethal mutant, *mts1-1*, and found it encodes Vps45p, a protein involved in vacuolar protein sorting (Vps; [@B8]; [@B37]). The Vps pathway is defined by \>40 complementation groups whose proteins are required for the transport of a number of soluble and membrane-bound proteins, including CPY, protease A (PrA), and carboxypeptidase S (CPS) from the late Golgi/TGN to the vacuole ([@B55]; [@B9]). This pathway is also essential for proper assembly of the vacuolar ATPase ([@B43]). However, the type II vacuolar membrane protein alkaline phosphatase (ALP) follows an alternate intracellular pathway to the vacuole ([@B43]; [@B30]; [@B9]; Piper et al., 1997). Few *vps* mutants prevent localization of ALP to the vacuolar membrane and its arrival at the vacuole is not dependent upon transport through the cell surface. The requirement for Apm3p in the absence of Vps45p suggested the possibility that at least one of these routes to the vacuole must be functional for survival and led us to examine ALP sorting in the AP-3 mutants. We show here that yeast AP-3 is essential for the transport of ALP via the alternative pathway to the vacuole.

Materials and Methods
=====================

Strains, Media, and Genetic Methods
-----------------------------------

Strains used in the study are listed in Table [I](#TI){ref-type="table"}. Rich yeast extract peptone dextrose (YEPD), rich yeast extract peptone glycerol (YEPG), synthetic minimal (SM), and synthetic dropout (C-nutrient) media were prepared as described previously ([@B56]). Yeast mating, sporulation, and tetrad analyses were performed essentially as described in [@B17].

Synthetic growth phenotypes caused by *apm3-Δ* combined with other mutant loci were examined by crossing single mutant strains and isolating double mutant progeny from dissection of heterozygous diploids. The double mutants were then transformed with an *APM3*, *CEN* plasmid or no plasmid, and the growth of the isogenic pair at 25°, 30°, 34°, and 37°C was compared by streaking for singles colonies on the same YEPD plate.

Plasmids
--------

*APM3* subclones were generated from pJW4, a *SNF5* clone from M. Carlson (Columbia University, New York, NY). (*APM3* lies upstream of *SNF5* on chromosome II.) pDS13 contains the *APM3* 2.3-kb *Pvu*2 fragment from pJW4 cloned into the Sma1 site of pBluescript SK^+^ (*APM3* is oriented in the Sac1 to Kpn1 direction of the polylinker). pDS14 is identical to pDS13 except the insert is in the opposite orientation. pDS19 contains the *APM3* 2.3-kb BamH1--Pst1 fragment from pDS13 cloned into pASZ11, an *ADE2*, *CEN* vector ([@B57]). pDS20 (*APM3*, *TRP1*, *CEN*) contains the 2.3-kb BamH1--Pst1 fragment from pDS13 cloned into pRS314 ([@B52]). pDS24 (*APM3*, *URA3*, *CEN*) contains the 2.3-kb BamH1--Sal1 fragment from pDS14 cloned into pRS316 ([@B52]). pDS27, containing *VPS45*, was cloned from the YCp50 library of [@B47]. To generate the *VPS45*, *URA3* integrating vector (pDS31), the 2.1-kb Sma1--Sph1 fragment from pDS27 was subcloned into YIp352 ([@B21]). pDS31 was linearized with Nhe1 to target integration at the *VPS45* locus. pRCP56, carrying the *vps45-13* ts for function allele of *VPS45* was described in [@B37]. p*END4*, *CEN* was from H. Riezman (University of Basel, Basel, Switzerland). In YCpKX22, the *KEX2* gene is under the control of the *TDH3* glyceraldehyde-3-phosphatase dehydrogenase (GAPDH) promoter in YCp50. This results in an ∼25-fold overproduction of Kex2p ([@B67]).

Gene Disruption of APM3
-----------------------

The *apm3-Δ*::*HIS3* disruption was generated by integration of a PCR fragment ([@B3]) using the following oligonucleotides: 5′ primer: 5′-GTGCAACAGCTCCCTCCTTCAAGCACCTGTGGACCCGCGTTCGTACTCTTGGCCTCCTCTAG-3′, and 3′ primer: 5′-GCCTTACTTGAAAATTGCCTGTCTGGGTCTTATACTTTGCACCCTCGTTCAGAATGACACG-3′. This results in the replacement of the *APM3* sequence coding for amino acids 36--468 (Apm3p is 483 amino acids long) by the *HIS3* gene. PCR reactions (100 μl) contained 1.4 ng *HIS3* template DNA (pUC-*HIS3*; [@B48]), 100 pmol each primer, 20 mM Tris-HCl, pH 8.3, 25 mM KCl, 0.05% Tween 20, 1.5 mM MgCl~2~, 100 μg/ml gelatin, and 200 μM dNTPs. Amplification was performed as follows: 5 min at 95°C; 2 cycles of 30 s at 94°C, 30 s at 45°C, 2 min at 74°C; 30 cycles of 30 s at 94°C, 30 s at 50°C, 2 min at 74°C; 7 min at 72°C. The ∼950-bp product was purified and transformed into diploid SL1528 to generate the *apm3-Δ*/*APM3* heterozygote, SL1650. As expected for *apm3-Δ* ([@B35]), tetrad analysis of this diploid yields four viable spores (two His^+^ and two His^−^) that have wild-type growth at all temperatures. The disruption was confirmed by DNA blot analysis (data not shown).

Synthetic Lethal Screen and Cloning of MTS1
-------------------------------------------

Unless otherwise noted, growth was performed at 30°C. The synthetic lethal screen was a modification of the *ADE2*/*ade2* sectoring method originally described in [@B5]. Strains SL1904 (*MAT* **a** *ade2 apm3-Δ*::*HIS3*) and SL1922 (*MATα ade2 apm3-Δ::HIS3*) each carrying the *ADE2*, *APM3*, *CEN* plasmid, pDS19, were mutagenized with methane sulfonic acid ethyl ester (EMS) to ∼50% killing and then plated on YEPD. The parental strains (Ade2^+^) formed white colonies that readily sector to red (Ade2^−^), since they do not require the *APM3*-plasmid for survival. A screen of ∼13,000 colonies yielded 204 candidates that had lost the ability to sector (Sect^−^) and could be dependent on plasmid-borne *APM3* for survival. These were restreaked for singles on YEPD twice and rescored for sectoring each time. Since *ade2 pet* strains remain white and would give false positives in this screen, Sect^−^ candidates were also tested for mitochondrial function by growth on glycerol medium (YEPG) and by a 2,3,5-triphenyltetrazolium chloride overlay assay ([@B33]). The remaining 79 candidates were then tested for dependence of the Sect^−^ phenotype upon the plasmid-borne *APM3*, as opposed to other plasmid sequences, by a plasmid shuffle test. Each candidate was transformed with pDS24 (*APM3*, *URA3*, *CEN*) and then tested for the ability to now lose the *APM3*, *ADE2* plasmid. Only 10 candidates were able to sector to red upon transformation with the second *APM3* plasmid. These candidates were backcrossed to an *apm3-Δ* strain of the opposite mating type (SL1904 or SL1922) to test for dominance of the sectoring phenotype. All backcrossed diploids were Sect^+^, indicating that all of the mutations were recessive. These diploids were then dissected and tetrads were scored for 2:2 segregation of the Sect^−^ phenotype. Eight candidates were discarded because tetrads from backcrosses showed nonstandard segregation, or there was complete loss of the Sect^−^ phenotype. The remaining two candidates showed 2:2 segregation of the Sect^−^ phenotype and were designated *mts1-1* and *mts2-1.*

*MTS1* was cloned by complementation of the ts growth phenotype of *mts1-1* cells. The original *mts1-1* isolate was backcrossed three times to SL1904, resulting in SL2163 (*ade2 apm3-Δ*::*HIS3 mts1-1* + pDS19). This strain was transformed with a YCp50 yeast genomic library ([@B47]) and spread plated onto C-uracil (C-Ura) plates. Colonies were allowed to grow at 25°C for 24 h and were then incubated at 37°C for 2 d. One colony (designated A1), which grew much faster than the others, was restreaked for single colonies onto C-Ura and incubated at 25° or 37°C. The A1 transformant was also tested for restoration of the sectoring phenotype on YEPD at 30°C. Both ts and loss of sectoring were rescued by this plasmid (redesignated pDS27). pDS27 also complemented the *mts1-1* mutation after retransformation of the parental strain (SL2163) with the isolated plasmid that had been shuttled through bacteria. Both ends of the pDS27 insert were sequenced using primers that recognize the 5′ and 3′ sides of the BamH1 library cloning site in YCp50 as described previously ([@B56]). The sequence was compared to the *Saccharomyces* Genome Database (SGD).

Antibodies
----------

ALP, CPY, and affinity purified Kex2p rabbit antisera were gifts from S. Nothwehr (University of Missouri, Columbia, MO), E.W. Jones (Carnegie Mellon University, Pittsburgh, PA) and R. Fuller (University of Michigan, Ann Arbor, MI), respectively. Mouse monoclonal antibody 13D11 (anti-Vat2p) was the gift of P. Kane (Syracuse University, Syracuse, NY). ALP antibodies were affinity purified against the maltose binding protein--ALP (MBP--ALP) fusion protein construct described in [@B31] using standard methods ([@B20]).

Preparation of Whole Cell Extracts and Subcellular Fractions for Immunoblotting
-------------------------------------------------------------------------------

Whole cell extracts were generated by glass bead homogenization in 4% SDS and prepared for immunoblotting as described previously ([@B27]). Subcellular fractionation was based on the procedure described in [@B22]. Strains were grown to mid-log phase and 10^9^ cells were harvested by centrifugation. Cell pellets were resuspended and incubated in 6 ml spheroplast buffer (1.2 M sorbitol, 50 mM KPO~4~, 40 mM β-mercaptoethanol, pH 7.5) plus 100 μg oxalyticase (Enzogenetics, Corvallis, OR) for 30 min at 30°C. Spheroplasts were pelleted and then resupended with 1.5 ml lysis buffer (0.2 M sorbitol, 50 mM Tris-HCl, 1 mM EDTA, pH 7.5) plus a protease inhibitor cocktail (PIC; [@B56]). Lysis was achieved by dounce homogenization (10 strokes), and unlysed cells and debris were removed by centrifugation at 450 *g* for 3 min, and then washed with lysis buffer plus PIC, and recentrifuged. The two supernatants were combined and centrifuged at 13,000 *g* for 15 min, generating S13K and P13K. The S13K was further centrifuged at 100,000 *g* for 60 min resulting in S100K and P100K. Pellets were resuspended to equal volume and samples of each fraction were taken. Equivalent volumes were separated by SDS-PAGE (7.5% acrylamide) and transferred to nitrocellulose. Blots were probed with affinity purified anti-ALP (1: 500), followed by goat anti--rabbit HRP (Zymed Labs, South San Francisco, CA) (1:5,000) as the secondary antibody. Immunoblots were developed by incubation with a mixture of equal parts solution A (2.5 mM luminol, 400 μM *p*-coumaric acid, 100 mM Tris, pH 8.5) and solution B (5.4 mM H~2~O~2~, 100 mM Tris, pH 8.5) for 1 min, and then exposure to X-ray film.

Cell Labeling and Immunoprecipitation
-------------------------------------

For CPY processing, a modification of the method of [@B43] was used. Cells were grown to log phase (1 to 2 × 10^7^ cells/ml) in SM plus requirements for nutritional markers. Cells (5 × 10^6^) were harvested, washed, and resuspended with 500 μl fresh growth medium containing 50 mM KPO~4~, pH 5.7, and 1 mg/ml BSA. Pulse labeling was initiated by addition of ^35^S-EasyTag (NEN Life Science Products, Boston, MA) to 200 μCi/ml for 10 min at 30°C. Samples were chased by addition of 100× CHASE (0.3 M NH~3~SO~4~, 1% methionine, 1% cysteine) and further incubated for 30 min. Cells (I, intracellular) were harvested by centrifugation and the medium (E, extracellular) was transferred to another tube containing 20 μl of PIC (see above). The E samples were diluted with 415 μl water and 100 μl 10× immunoprecipitation (IP) buffer (0.9 M Tris-HCl, pH 8.0, 1% SDS, 1% Triton X-100, 20 mM EDTA), heated at 100°C for 5 min, and then stored on ice. The cell pellets (I) were resuspended in 100 μl 2% SDS, transferred to a tube containing 0.15 g glass beads, vortexed on high for 3 min, and heated at 100°C for 5 min. Glass beads and insoluble material were sedimented in a microcentrifuge for 1 min and the soluble cell extract was transferred to a new tube. The glass beads were washed once with 100 μl TBS (50 mM Tris-HCl, 150 mM NaCl, pH 8.0), and the extract supernatants were combined. The I samples were then diluted with 80 μl 10× IP buffer and 720 μl of water. I and E samples were preabsorbed with preswollen protein A--Sepharose ([@B56]). The supernatants from this treatment were then incubated with 3 μl of anti-CPY antiserum for 1 h. Immune complexes were collected with protein A--Sepharose and then beads were washed twice with 1× IP buffer. Immunoprecipitates were eluted in 40 μl 2× SDS-PAGE sample buffer and separated on an SDS 10% polyacrylamide gel. Fixation, enhancement, and autoradiography were performed as described previously ([@B56]).

Pulse-chase analysis of ALP processing was examined using methods described in [@B30] with the following modifications. Cells were labeled with 300 μCi/ml ^35^S-EasyTag (NEN Life Science Products), and chased for the indicated times as described above. Cell lysis was performed in the presence of PIC and preabsorbed with protein A--Sepharose as described for CPY above. For IP, samples were incubated with 1 or 2 μl of crude ALP antiserum for 2 h. Fixation, enhancement, and autoradiography were performed as described above for CPY. Quantification of ALP was performed by densitometry on autoradiograms using a Sci Scan 5000 (United States Biochemical Corp., Cleveland, OH), or by quantification of pixel density using a phosphorimager (Molecular Dynamics Inc., Sunnyvale, CA).

Immunofluorescence Microscopy
-----------------------------

Preparation of cells and staining with antibodies was performed essentially as described in [@B46]. Primary antibodies were used at a dilution of 1:50 (affinity purified anti-ALP, affinity purified anti-Kex2p, and anti--Vat2p 13D11 monoclonal). Secondary antibodies were FITC-conjugated goat anti--rabbit Ig (1:100, Kirkegaard and Perry Laboratories, Gaithersburg, MD) and Cy3-conjugated goat anti--mouse Ig (1: 1,000, gift of D. Loyaza and S. Michaelis, Johns Hopkins University, Baltimore, MD). All antibody incubations were for 1--2 h. Immunofluorescence visualization was performed on an epifluorescence microscope (Axioplan; Carl Zeiss, Inc., Thornwood, NY), and images were captured on a camera (CH250 CCD; Photometrics Ltd., Tucson, AZ) using CCD ImageCapture (Yale Univerity, New Haven, CT). Images were imported into Adobe Photoshop 3.0, labeled in Canvas 3.5 (Deneba Software, Miami, FL), and printed on a Tetronix 450 dye sublimation printer.

Results
=======

Synthetic Lethal Screen for Isolation of Mutants That Require Yeast AP-3 Function
---------------------------------------------------------------------------------

Strains deleted for any of the subunits of the yeast AP-3 complex grow normally and show no defects in secretion or sorting pathways previously found to be affected in *chc1* mutants (Fig. [1](#F1){ref-type="fig"}; [@B35]; data not shown). These pathways include trafficking of soluble vacuolar hydrolases ([@B50]), retention of late-Golgi resident proteins ([@B51]), and endocytosis ([@B58]). Therefore, we undertook a genetic approach to determine where the AP-3--like complex functions within the cell. A colony-sectoring synthetic lethal screen ([@B5]) was used to identify mutations in other genes that require the presence of Apm3p for survival. In this strategy, parental strains were of *ade2 apm3-Δ::HIS3* genotype, carrying the wild-type (*wt*) *ADE2* and *APM3* genes on a plasmid (pDS19). These strains form white colonies because of the presence of the plasmid-borne *ADE2*, but can readily sector red (Ade2^−^) on nonselective medium, because the *APM3* gene is not essential. A pair of strains of opposite mating type were mutagenized with EMS and then colonies scored for the requirement of the *APM3* plasmid as measured by inability to sector red (Sect^−^). From a total of ∼13,000 colonies screened, two Sect^−^ mutants were isolated and designated *mts1-1* and *mts2-1.*

Initial characterization of the *mts* mutants indicated that *mts1-1*, but not *mts2-1*, is ts for growth at elevated and low temperatures (34°, 37° and 16°C; data not shown). In addition, sorting assays demonstrated that *mts1-1* has a *vps* defect (Fig. [1](#F1){ref-type="fig"}). Normally, CPY is made as a precursor whose terminal glycosylation in the Golgi yields 69-kD p2CPY. Vacuolar delivery results in *PEP4*-dependent cleavage of CPY to the active, mature 61-kD form (mCPY). In *vps* mutants, p2CPY is secreted from the cell ([@B55]). The pulse-chase analysis in Fig. [1](#F1){ref-type="fig"} illustrates the accumulation of p2CPY in the extracellular fraction of the *mts1-1*, but not the *mts2-1* mutant strain. As we described previously ([@B35]), normal CPY processing and sorting were observed in an *apm3-Δ* strain. The CPY sorting defect associated with *mts1-1* suggested that it may be allelic to an already identified *VPS* gene.

MTS1 Is VPS45
-------------

The *MTS1* gene was cloned by complementation of the *mts1-1* ts growth phenotype at 37°C by transformation with a yeast genomic DNA library. One complementing plasmid was obtained and the sequence was determined from each end of the genomic DNA insert. The resulting sequences were compared to the SGD and found to correspond to a region on the left arm of chromosome VII. The only complete open reading frame within the insert was the class D *VPS* gene *VPS45*, which encodes a member of the Sec1 protein family ([@B8]; [@B37]). Most class D *VPS* gene products are believed to be involved in the fusion of postGolgi vesicles with an endosome-like organelle referred to as the prevacuolar compartment (PVC; Fig. [2](#F2){ref-type="fig"}; [@B43]; [@B8]; [@B37]; [@B4]; [@B7]; [@B65]). Mutants in this *vps* class accumulate intracellular vesicles, have a large central vacuole, and exhibit defects in vacuole inheritance and acidification. Upon further analysis we also found that *mts1-1* mutant cells have vacuolar acidification and inheritance defects (data not shown). Confirmation that *mts1-1* is allelic to *VPS45* was obtained by showing that the temperature sensitivity of *mts1-1* cells was not complemented upon crossing to a *vps45-4* strain and by integrative transformation and segregation analysis (data not shown).

apm3-Δ Causes Synthetic Growth Phenotypes with Nearly All Class D vps Mutants
-----------------------------------------------------------------------------

Since *apm3-Δ* showed synthetic lethality with the class D mutant *vps45* in the sectoring screen, we investigated whether other *vps* mutations cause synthetic growth phenotypes when combined with *apm3-Δ* (Fig. [2](#F2){ref-type="fig"}; Table [II](#TII){ref-type="table"}). The *vps* mutants have been classified into six groups (A--F) based primarily on vacuolar morphology and localization of vacuolar proteins ([@B43]). In general, these classes represent distinct intermediate steps along the transport pathway that CPY and other vacuolar hydrolases take from the Golgi to the vacuole (for review see [@B55]). Growth was examined at various temperatures in isogenic pairs of *apm3-Δ vps* double mutants with and without a complementing *APM3* plasmid (Table [II](#TII){ref-type="table"}). We observed synthetic growth defects when *apm3-Δ* was combined with all class D *vps* mutants, with the exception of *vps34.* However, it has been proposed that Vps34p and Vps15p may function at a step in the *vps* pathway distinct from other class D mutants (Fig. [2](#F2){ref-type="fig"}) ([@B43]; [@B25]; [@B55]). In addition, we saw no synthetic interaction of *apm3-Δ* with *vps8-Δ*, which has recently been reclassified as a potential class D *vps* mutant ([@B23]).

Significant variation in the severity of the growth defects was seen when *apm3-Δ* was combined with the class D mutants. This may be because of the fact that *vps* null alleles result in stronger genetic interactions with *apm3-Δ* than *vps* alleles that result in partial loss of function (e.g., compare *apm3-Δ vps45-Δ* and *apm3-Δ vps45-13^ts^*). However, in other cases, it appears that the differences in the strength of the growth phenotype reflect differences in the functions of the Vps proteins. For example, *apm3-Δ pep12-Δ* and *apm3-Δ vps45-Δ* have much more severe growth phenotypes than *apm3-Δ pep7-Δ*. Interestingly, in crosses we found *apm3-Δ mts1-1* spore segregants were viable, although they showed a very severe synthetic growth phenotype. Similar results were obtained when mutants in each of the other components of the yeast AP-3 complex were crossed with *mts1-1* (data not shown).

Among the other *vps* mutants, a synthetic growth defect was observed when *apm3-Δ* was combined with a deletion of *VPS1*, which codes for the dynamin homologue involved in vesicle budding from the late Golgi for transport to the vacuole ([@B59]; [@B30]). Note that the other class F mutant (*pep8*/*vps26*) showed no synthetic growth phenotype when combined with *apm3-Δ*. We also found a weak genetic interaction between *apm3-Δ* and *vps33*, but no other class C *vps* mutant tested (Table [II](#TII){ref-type="table"}). Class C mutants have little or no visible vacuoles and affect a late transport step from the prevacuole/endosome to the vacuole ([@B43]; [@B10]). Interestingly, Vps33p is another member of the Sec1p/Vps45p family involved in vesicle fusion ([@B2]; [@B61]), suggesting possible overlap in the function of Vps45p and Vps33p. However, there does not seem to be a general effect of *apm3-Δ* on mutants for all Sec1p family members, since no such interaction was observed between *apm3-Δ* and *sec1-1* (Table [II](#TII){ref-type="table"}).

We also tested for genetic interactions between *apm3-Δ* and several other mutations affecting the late secretory and endocytic pathways (Table [II](#TII){ref-type="table"}; Fig. [2](#F2){ref-type="fig"}). No synthetic growth phenotypes were observed when *apm3-Δ* was combined with the late secretory mutants *sec1-1*, *sec4-8*, or *sec6-4* ([@B32]), indicating that the simple accumulation of vesicles is not sufficient for the synthetic growth defects described above. No effect of *apm3-Δ* was observed in a *dnm1-Δ* mutant, which lacks a dynamin homologue involved in late endocytic transport ([@B14]). The *apm3-Δ* mutant did lower the permissive growth temperature of *end3-1* and *end4-1* mutants, which are defective in the internalization step of endocytosis ([@B42]). This contrasts with our earlier findings showing that AP-3 mutants, in fact, suppress the growth and a-factor receptor internalization defects of strains mutant for yeast PM casein kinase 1 ([@B35]). Therefore, loss of AP-3 function does not suppress the growth phenotype of all endocytic mutants.

Since class D *vps* mutants have multiple phenotypes, additional crosses were made in an effort to gain information about which defect(s) was responsible for the genetic interaction with *apm3-Δ* (Table [II](#TII){ref-type="table"}). Mutations in several of the *VAC* genes (e.g., *VAC8*) result in vacuole inheritance defects, yet sorting of CPY is not affected ([@B64]). However, the growth of the *apm3-Δ vac8-Δ* double mutant was normal. Class D *vps* mutants also are defective for acidification of the vacuole ([@B43]). *VMA2*/*VAT2* encodes the 60-kD peripheral membrane regulatory subunit of the vacuolar ATPase ([@B68]), but, again, *apm3-Δ* did not alter the growth of *vat2-Δ* cells. These data indicate that interruption of the transport function in class D *vps* mutants is most likely responsible for the synthetic growth phenotypes observed when combined with *apm3-Δ*.

Transport and Processing of ALP Are Defective in apm3-Δ Cells
-------------------------------------------------------------

The genetic interactions described above suggested that in the absence of the vesicular transport step performed by the class D Vps proteins the function of Apm3p, and hence the AP-3 complex, becomes crucial. We considered the possibility that essential endosomal or vacuolar processes require the function of at least one route to the vacuole, and that the AP-3 mutants blocked one of these pathways. The endocytic pathway to the vacuole was not a likely candidate because we have previously shown that AP-3--deficient cells have normal internalization and degradation of Ste3p ([@B35]). Therefore, we tested whether the second internal pathway from the late Golgi to the vacuole, parallel to the Vps pathway, was affected in the absence of the AP-3 complex. This pathway has been defined by the vacuolar membrane protein, ALP, whose localization on the vacuole is independent of many of the *VPS* gene products, including the class D proteins ([@B43]; [@B9]; Piper et al., 1997). First, we examined the processing of ALP in *apm3-Δ* strains by pulse-chase/immunoprecipitation analysis (Fig. [3](#F3){ref-type="fig"} *A*). In *wt* cells precursor ALP (pALP) was transported to the vacuole and underwent *PEP4*-dependent proteolytic maturation with a half-time of ∼6 min. In contrast, in the *apm3-Δ* mutant ALP processing was severely delayed, extending the half-life of pALP to ∼45 min (average of 5 experiments). Interestingly, by 120 min the major species in *apm3-Δ* cells was a smaller, abberantly processed form (\*ALP), which migrated at ∼66 kD. Vacuolar proteases were required for processing of ALP in *apm3-Δ* cells, as only pALP accumulated in an *apm3-Δ pep4 prb1* strain (Fig. [3](#F3){ref-type="fig"} *B*). These data suggested that some ALP was delivered to the vacuole in *apm3-Δ* cells, albeit with slowed kinetics. Alternatively, this ALP processing may have occurred in a novel compartment containing *PEP4*-dependent hydrolytic activity.

The ALP processing defect in *apm3-Δ* cells was also observed at steady state as shown by immunoblotting of whole cell extracts (Fig. [3](#F3){ref-type="fig"} *B*). In *wt* cells ALP exists predominantly as mature ALP (mALP) with a small amount of \*ALP at steady state. However, in *apm3-Δ* cells, pALP was also a major species. Cells carrying a deletion in any of the four AP-3 subunit-encoding genes (*apl5-Δ*, *apl6-Δ*, *apm3-Δ*, and *aps3-Δ*) gave the identical distribution of ALP (Fig. [3](#F3){ref-type="fig"} *B*). ALP processing was normal in strains carrying a mutation in each of the other yeast AP μ chain-encoding genes (*apm1-Δ*, *apm2-Δ*, and *apm4-Δ*) or combinations of these, and none of these other mutants enhanced the ALP phenotype when combined with *apm3-Δ* (data not shown).

Since ALP was delayed in transport to the vacuole in *apm3-Δ* cells, we investigated the location of ALP by subcellular fractionation (Fig. [4](#F4){ref-type="fig"}). As expected, in *wt* cells the vast majority of mALP pelleted at 13,000 *g*, which sediments vacuoles as well as PM, ER, and other large membrane organelles ([@B22]). However, in *apm3-Δ* cells the three forms of ALP fractionated independently. The distribution of mALP was similar to that in *wt* cells, predominantly in the P13K fraction. In contrast, pALP was found in the high speed pellet (P100K) where Golgi, endosomes, and other small organelles and vesicles sediment ([@B60]), suggesting accumulation in a novel compartment. \*ALP remained soluble even after the high speed spin (S100K). Because of its solubility and size, it is likely that \*ALP is a product of a cleavage(s) at the lumenal juxtamembrane region of the protein, resulting in a soluble form that is released during lysis and fractionation from a compartment(s) that is osmotically fragile. The cleavage of ALP at the juxtamembrane region would remove as many as half of the sulfur-containing amino acids from the protein. This could explain the apparent loss of total ALP signal during the course of the pulse-chase analysis (Fig. [3](#F3){ref-type="fig"} *A*).

ALP Is Mislocalized in apm3-Δ cells
-----------------------------------

The delayed processing and subcellular fractionation of ALP suggested that ALP is missorted and may localize to a novel compartment. Therefore, we used immunofluorescence microscopy to localize ALP in *apm3-Δ* cells (Fig. [5](#F5){ref-type="fig"}). As expected, in *wt* cells affinity-purified ALP antibodies stained the vacuole membrane, colocalizing with the vacuolar ATPase. The vacuolar staining pattern for the ATPase was normal in the *apm3-Δ* mutant, consistent with our findings that the Vps pathway is intact in AP-3 mutants. In contrast, in the *apm3-Δ* mutant ALP staining was detected primarily in a large number of small punctate structures throughout the cell. Infrequently, faint rim staining of the vacuole was seen, which was often more visible in *pep4* strains (see Fig. [8](#F8){ref-type="fig"} *C*). Nevertheless, even in *pep4* strains, the punctate pattern was predominant.

Previous immunofluorescence studies have shown that yeast Golgi or late Golgi proteins display a distinctive staining pattern with several spots localized throughout the cytoplasm ([@B44]; [@B16]). Therefore, we examined whether the ALP staining in AP-3 deficient cells was consistent with such a Golgi pattern by localizing Kex2p, a late Golgi/TGN marker. As shown in Fig. [6](#F6){ref-type="fig"}, the Kex2p localization was identical in *wt* and *apm3-Δ* cells, each showing the characteristic Golgi pattern of ∼10 large spots in each cell. This was quite distinct from the overall smaller size and larger number of spots observed for ALP staining in the *apm3-Δ* mutant (Fig. [5](#F5){ref-type="fig"}). We conclude that the overall structure of the Golgi and vacuole appear normal in cells lacking AP-3 function, but substantial ALP accumulates in a distinct compartment.

Since immunofluorescence analysis indicated that ALP accumulates in small membrane structures in *apm3-Δ* cells, we examined isogenic *wt* and mutant cells by thin section transmission EM using two different fixation/staining methods ([@B24]; [@B15]). Upon examination of \>50 cells of each genotype by each method, we found that *wt* and *apm3-Δ* cells had the same types and similar numbers of membrane structures (data not shown). Surprisingly, we observed no accumulation of small vesicles in the *apm3-Δ* cells. This suggests that ALP may accumulate in a normally occurring, preexisting membrane compartment(s) in AP-3--deficient yeast.

Partial Rerouting of ALP through the Vps Pathway in apm3-Δ Mutants
------------------------------------------------------------------

The pulse-chase and immunoblot analyses of AP-3 mutants (Fig. [3](#F3){ref-type="fig"}) indicated that some ALP arrives at the vacuole and is processed to the mature form, albeit slowly. If the normal ALP pathway is blocked, it could arrive at the vacuole by rerouting through the cell surface followed by endocytosis, as it does in a *vps1* mutant ([@B30]). Alternatively it could be delivered to the vacuole by the Vps pathway as it does when the sorting information in the ALP cytoplasmic tail is removed ([@B9]; Piper et al., 1997). To investigate whether ALP traffics through the cell surface in AP-3 mutants, we compared ALP processing in an *apm3-Δ end4-1* strain with its isogenic *apm3-Δ END4* counterpart. If rerouting of ALP to the vacuole requires endocytosis, we would expect the *end4* mutation to further slow or block ALP processing in the *apm3-Δ* mutant. However, the kinetics and degree of processing of ALP at 37°C were identical in the *apm3-Δ* strain with or without End4p function (Fig. [7](#F7){ref-type="fig"} *A*). Combining *apm3-Δ* with *end3-1* or *sec1-1* also did not further delay the processing of ALP (data not shown), demonstrating that ALP does not transit the PM in AP-3--deficient cells.

To test whether residual ALP processing in AP-3 mutants occurred by rerouting through the Vps pathway, we combined *apm3-Δ* with the *vps45-13* mutation, which causes a temperature-dependent *vps* phenotype ([@B37]). It was important to use an allele that is ts for function, since a constitutive block of the Vps pathway, as would occur with *vps45-Δ*, would deplete the vacuole of hydrolytic activity and prevent pALP processing with or without *apm3-Δ*. An *apm3-Δ vps45-13* mutant and an isogenic *apm3-Δ VPS45* strain were grown at 25°C and then shifted to 37°C for pulse-chase labeling and IP (Fig. [7](#F7){ref-type="fig"} *B*). In this case pALP was significantly stabilized by the presence of the *vps45-13* mutation. In other control experiments (data not shown) we found that at 25°C, the processing of ALP in the *apm3-Δ vps45-13* mutant was identical to that of *apm3-Δ* alone. Also, the isogenic *APM3 vps45-ts* strain gave *wt* processing of ALP at 37°C. Moreover, the CPY processing/sorting defect of *vps45-13* was dependent upon the shift to 37°C, but independent of *APM3* (data not shown). This indicates that vacuolar hydrolytic activity was present in the cell at the time of the shift to the nonpermissive temperature even though the *vps45-ts* allele caused a temperature-dependent block in the Vps pathway. Therefore, pALP was rerouted through the Vps pathway in the AP-3--deficient strain and was unable to continue to the vacuole in the *apm3-Δ vps45-13* strain at 37°C. Interestingly, there was still a significant accumulation of \*ALP in the *apm3-Δ vps45-13* mutant at 37°C, although it appeared with slower kinetics than in the *apm3-Δ VPS45* strain (Fig. [7](#F7){ref-type="fig"} *B*). The compartment where this processing occurs is still not clear.

Loss of AP-3 function Allows Membrane Cargo Trapped in the Vps Class E Prevacuole to Be Delivered to the Vacuole
----------------------------------------------------------------------------------------------------------------

The above studies suggested that some ALP was delivered to the vacuole via the Vps pathway and not via endocytosis in *apm3-Δ* cells. We thought it should also be possible to confirm these findings by immunofluorescence localization of ALP in appropriate double mutants. Consistent with the pulse-chase analysis, ALP did not accumulate at the cell surface in *apm3-Δ end4-1* cells shifted to 37°C, but showed the identical staining pattern to that of *apm3-Δ END4* cells (data not shown). This supports our conclusion that ALP takes an intracellular pathway(s) in AP-3 mutants.

To examine traffic through the Vps pathway, we took advantage of a class E *vps* mutant, *vps4*, which accumulates an exaggerated endosomal/prevacuolar compartment (class E compartment/PVC; [@B43]; [@B1]; [@B13]). In class E mutants late Golgi proteins (e.g., DPAP-A), the vacuolar ATPase, endocytosed cell surface receptors (e.g., Ste2p), and the CPY sorting receptor (Vps10p) become trapped in the class E PVC and appear as one or two large bright dots adjacent to the vacuole by immunofluorescence ([@B43]; [@B38]; [@B1]; [@B6]; [@B13]). In contrast, ALP localization to the vacuolar membrane is unaffected in class E *vps* mutants ([@B43]; Piper et al., 1997). Therefore, we reasoned that if ALP is partially rerouted through the Vps pathway in the absence of AP-3 function, we might observe accumulation of ALP in the class E PVC in an *apm3-Δ vps4* double mutant. In agreement with previous studies with class E mutants, the V-ATPase and the late Golgi marker, Kex2p, localized to one or two large perivacuolar spots, whereas ALP resided in the vacuole membrane in *vps4* cells expressing Apm3p (Fig. [8](#F8){ref-type="fig"}, *A* and *B*). However, in the *vps4 apm3-Δ* mutant, ALP did not accumulate in a perivacuolar region, but showed a similar dispersed punctate staining throughout the cell (Fig. [8](#F8){ref-type="fig"} *C*) as seen with the *apm3-Δ* mutation alone. More to our surprise, when *vps4 apm3-Δ* cells were stained to localize the V-ATPase, the class E compartment had disappeared and the ATPase subunit was found on the vacuole membrane (Fig. [8](#F8){ref-type="fig"} *C*). Kex2p also appeared on the vacuolar membrane colocalizing with the V-ATPase in *vps4 apm3-Δ* cells (Fig. [8](#F8){ref-type="fig"} *D*). These results indicate that the *apm3-Δ* mutation did not actually suppress the class E *vps* phenotype, since Kex2p (and presumably other late Golgi proteins) did not recycle to the Golgi, but rather was transported to the vacuole. In addition, p2CPY was still secreted from the cell in the double mutant (data not shown). Similar results were obtained in *vps27-Δ apm3-Δ* cells (data not shown), indicating that this was not specific to the *vps4* class E mutant. These findings suggest that the loss of Apm3p allowed the class E prevacuole to fuse directly with the vacuole membrane. Alternatively, prevacuolar structures might have acquired the ability to fuse with themselves and/or mature into a larger vacuole-like organelle (see Discussion). However, substantial ALP was still trapped in small vesicular organelles, distinctive to the AP-3 mutants.

Discussion
==========

Since the identification of AP-3 in animal cells, much effort has been directed at determining the function of this novel adaptor-related complex. This complex does not appear to colocalize or copurify with clathrin and, therefore, may function independently of clathrin coats ([@B28]; [@B53]; [@B12]; [@B54]). Cytological studies have suggested that the mammalian AP-3 complex is involved in transport from the TGN or functions in an endosomal compartment ([@B53]; [@B11]; [@B54]). Further information on the function of AP-3 came from the finding that the *garnet* gene of *Drosophila* encodes a protein closely related to the δ subunit of AP-3 ([@B34]; [@B54]). Mutations in *garnet* lead to reduced pigmentation of the eyes and other tissues. Pigment cells are present, but these have few or no pigment granules, which are thought to be lysosome-like organelles. Therefore, it was suggested that AP-3 might be involved in sorting to or biogenesis of lysosomal organelles. Our studies showing a requirement of AP-3 for processing and sorting of ALP support this idea, and provide direct functional evidence that the AP-3 complex is required for sorting to the vacuole, a lysosome-like compartment. Interestingly, the pathway that AP-3 mutants block is not the well studied Vps pathway, but the alternate route. This is consistent with the hypothesis that the *garnet* mutations affect formation of a specialized lysosome-like organelle, which might have different trafficking requirements for biogenesis than normal lysosomes.

Where the yeast AP-3 complex functions in the alternative pathway from the late Golgi to the vacuole still needs to be defined. Presumably, the AP-3 complex serves as a coat protein; binding to cytoplasmic tails, sequestering cargo proteins, and directing vesicle formation. It is possible that the AP-3 complex binds to the cytoplasmic face of the late Golgi/TGN, directing selective cargo (e.g., ALP) away from the secretory and Vps pathways. The pALP that accumulated in the *apm3-Δ* mutant sedimented at 100,000 *g* where Golgi, endosomes, and small vesicles are found. However, immunofluorescence staining indicated that ALP localized to structures distinct from the late Golgi protein Kex2p, which showed a normal localization pattern. Also, ER and Golgi modifications of ALP occurred with normal kinetics in AP-3 mutants (Fig. [3](#F3){ref-type="fig"} *A*), suggesting that both early and late compartments of the Golgi are unaffected in the absence of the adaptor. Nonetheless, the AP-3 complex could function at the late Golgi/ TGN and ALP becomes trapped in a subcompartment budding from this organelle.

We also found that substantial ALP was diverted to the Vps pathway in the AP-3 mutants, but its processing was very slow. Therefore, the ALP-staining structures may represent a normal subcompartment along the Vps pathway and this was visualized in the *apm3* mutant because ALP\'s transit through this compartment was delayed. Independent studies have indeed shown that when the sorting information in the cytoplasmic tail of ALP is mutated, it traffics through the Vps pathway, resulting in a kinetic delay in the mutant protein\'s arrival at the vacuole (Piper et al., 1997). However, the mutant ALP did not appear to localize with the punctate staining pattern we observed in the AP-3 mutant.

This raises an alternative possibility: ALP is able to enter its normal trafficking pathway but becomes trapped in an intermediate compartment in the adaptor mutant. In this case, AP-3 might not be involved directly in cargo selection at the late Golgi, but could function at some later compartment, such as another endosomal/prevacuole intermediate. Over time, sorting receptors or other membrane components of the sorting machinery might not be recycled to the Golgi, resulting in ALP slowly leaking into the Vps pathway. The punctate staining pattern suggests that the ALP might be trapped in vesicles that cannot fuse with their target membrane, such as an endosomal compartment or the vacuole itself, although by EM there was no dramatic accumulation of vesicles like that seen with class D *vps* mutants. If such a fusion defect existed, it might be caused by reduced recycling of some component(s) (e.g., a vesicle-soluble-*N*-ethylmaleimide-sensitive factor attachment protein receptor \[v-SNARE\]) to the Golgi that would need to be included in transport vesicles for fusion at a later step.

An endosomal function for AP-3 is also consistent with the findings that AP-3 mutants partially suppress the growth and Ste3p internalization defects caused by yeast PM casein kinase 1 deficiency ([@B35]). If AP-3 functions at an endosomal compartment where the endocytic and Golgi to vacuole pathways overlap, loss of function of the complex might affect both the ALP pathway and a recycling pathway to the cell surface, resulting in the suppression of the kinase endocytic defect. The genetic interactions of *apm3-Δ* with *end3-1* and *end4-1* also suggest a possible functional overlap of an endocytic route and the ALP sorting pathway. Alternative possibilities are that AP-3 has more than one sorting function in the cell or that some of the proteins that normally traverse the ALP pathway are diverted to secretory vesicles and traffic to the cell surface in AP-3 mutants, where they might somehow suppress the *yck* endocytic defect. Identification of the kinase substrates and localization of the AP-3 complex within the cell should help clarify the connections of the AP-3 complex with both Golgi to vacuole transport and endocytosis.

Although it is not clear at what step the AP-3 complex functions in sorting ALP to the vacuole, existing mutations seem to define at least three distinct steps along this pathway (Fig. [9](#F9){ref-type="fig"}). The late acting Vps proteins, including Vps33p, a Sec1p homologue ([@B2]; [@B61]), Vam3p, a syntaxin-related target (t)-SNARE of the vacuole membrane ([@B10]; [@B29]; [@B63]), and Ypt7p, a Rab homologue ([@B66]; [@B18]; [@B62]), are thought to function in fusion of endosome- derived membranes or vesicles directly with the vacuolar membrane. These gene products appear to be required for the final stages of transport in both the Vps and ALP pathways. Vps41p/Vam2p ([@B9]; [@B26]) and Vps39p/Vam6p, which were recently shown to physically interact ([@B26]), may also act at a distinct, possibly later, step than AP-3. Null mutants of these genes show a block in both CPY sorting and ALP processing and also accumulate fragmented vacuoles containing the V-ATPase and ALP ([@B43]; [@B9]; [@B26]). *VPS41*/*VAM2* and *VPS39*/*VAM6* were also identified in a screen for *cvt* mutants, which are defective in the cytoplasm to vacuole transport pathway ([@B19]). However, recent studies using a *vps41-ts* allele suggested that the primary defect resulting from loss of Vps41p function is in the ALP pathway, since only after prolonged periods at the nonpermissive temperature did the *vps* sorting defect surface ([@B9]). These phenotypes are quite distinct from those found in AP-3 null mutants which exhibit no obvious *vps* phenotypes, localize the V-ATPase to the vacuole normally and show no extensive elaboration of any abnormal membrane organelles. AP-3 is also not required for the Cvt pathway (Huang, K., and S. Lemmon, unpublished observations). Therefore, the AP-3 complex most likely acts at a different step than the Vps41p(Vam2p)-- Vps39p(Vam6p) complex.

In our attempt to further characterize the pathway responsible for the residual ALP processing in AP-3 mutant cells we obtained an astonishing result. In the context of a *vps* class E mutant, loss of AP-3 function resulted in reappearance of the V-ATPase on the vacuolar membrane. Strictly speaking, this was not suppression of the class E phenotype(s) since Kex2p did not return to the Golgi, but was also transported to the vacuole. In addition, p2CPY was secreted from the cell (data not shown), indicating these cells retained their *vps* phenotype. Interestingly, ALP localization was still predominantly in small vesicular structures throughout the cytosol. One model to explain these observations is that a regulatory protein(s) normally sorted into the ALP--AP-3--dependent pathway becomes diverted through the Vps pathway in the AP-3 mutant. This might now enable fusion of the aberrant class E compartment with the vacuole or permit prevacuole--prevacuole fusion, which could mature into a large vacuolar-like organelle. A candidate for such a protein is Vam3p, which has recently been suggested to traffic through the ALP-- AP-3 pathway (Piper et al., 1997). In a normal cell it would be highly desirable for a t-SNARE, such as Vam3p, to bypass at least some compartments of the Vps pathway to prevent premature interaction with its v-SNARE partner, perhaps the newly identified Nyv1p ([@B29]). This sort of quality control system would be essential for maintenance of an endosomal/prevacuole compartment, from which proteins need to recycle to the Golgi and through which endocytic traffic must pass.

This model could also explain why the genetic interactions we observed were largely restricted to the combination of *apm3-Δ* with class D *vps* mutants, which are blocked before fusion with the prevacuole. Mutants which can form a functional prevacuole or acidifying compartment like the vacuole (such as class E, B, and A *vps* mutants; [@B43]) would be able to survive quite well even in the absence of AP-3 function. There is also evidence that some class D mutants have endocytic defects (*pep7*; [@B65], and *vps45*; our unpublished observations), suggesting that some components involved in vesicle fusion with the prevacuole may be shared by the endocytic and Golgi to vacuole pathways. In the absence of AP-3 and certain class D genes all three pathways to the vacuole would be blocked.

The model in Fig. [9](#F9){ref-type="fig"} shows the requirement of the AP-3 complex for transport of ALP from the late Golgi to the vacuole. At the present time, it is not clear how many intermediate steps there are along the ALP--AP-3 pathway. It is possible that there is a single vesicle intermediate for transport of ALP from the late Golgi directly to the vacuole, or that ALP traffics through a Vps-independent endosomal compartment. Although the model shown suggests AP-3 acts at the level of the late Golgi, as discussed above, it could act at such an endosomal intermediate (e.g., Fig. [9](#F9){ref-type="fig"} *B*). A more speculative model is considered in Fig. [9](#F9){ref-type="fig"} *B* in which Golgi-derived vesicles that follow the Vps pathway initially fuse with an early endosome, and that the ALP- (and Vam3p-) containing vesicles fuse with the late endosome. The Vps pathway would then converge with the ALP pathway at the late endosome/prevacuole. This idea allows for maintenance of an early endosome recycling compartment and is consistent with the observation that Vam3p, Vps33p, Ypt7p, and presumably other late acting Vps proteins are required for a late stage of transport to the vacuole of both ALP and proteins of the Vps pathway. It has been proposed that the class E compartment is an abnormal late endosome/prevacuolar compartment, since it appears as one or two bright spots next to the vacuole ([@B43]; [@B38]; [@B45]; [@B1]), and by EM it appears as stacks of curved membrane cisternae ([@B45]; [@B1]). However, recent studies indicate that the tubular structures of the aberrant class E organelle are more reminiscent of early endosomes observed in yeast ([@B40]). Moreover, morphological analysis of an *end13* mutant (*end13* is an allele of *VPS4* \[[@B25]\]) indicates endocytosis is retarded at an early, postinternalization endocytic step (Riezman, H., personal communication). As more gene products involved in the alternative ALP pathway to the vacuole are identified, it should be possible to resolve these two models.
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\*ALP

:   aberrantly processed ALP

ALP

:   alkaline phosphatase

AP

:   adaptor protein

CPY

:   carboxypeptidase Y

IP

:   immunoprecipitation

mALP

:   mature ALP

mts

:   *apm*three synthetic lethal mutant

pALP

:   precursor ALP

PIC

:   protease inhibitor cocktail

PVC

:   prevacuolar compartment

SNARE

:   soluble *N*-ethymaleimide-sensitive factor attachment protein receptor

ts

:   temperature sensitive

Vps

:   vacuolar protein sorting

*wt*

:   wild type

Another report on the role of yeast AP-3 in the sorting of ALP via the alternate pathway to the vacuole has been published recently (Cowles, C.R., G. Odorizzi, G.S. Payne, and S.D. Emr. 1997. The AP-3 adaptor complex is essential for cargo-selective transport to the yeast vacuole. *Cell*. 91:109--118). In addition, this work provided further evidence that Vam3p also traffics through the alternate pathway.

###### 

Strains Used in This Study

  Strain no.      Genotype                                                                                       Source
  ------------ -- ------------------------------------------------------------------------------------------- -- -------------
  SL1463          *MATα leu2 ura3-52 trp1 his3-Δ200*                                                             [@B35]
  SL1528          *MAT**a**/MATα leu2/leu2 ura3-52/ura3-52 trp1/trp1 his3-Δ200/his3-Δ200*                        This study
  SL1650          *MAT**a**/MATα apm3-Δ::HIS3/APM3 leu2/leu2 ura3-52/ura3-52 trp1/trp1 his3-Δ200/his3-Δ200*      This study
  SL1652          *MATα apm3-Δ::HIS3 leu2 ura3-52 trp1 his3-Δ200*                                                This study
  SL1653          *MATα apm3-Δ::HIS3 leu2 ura3-52 trp1 his3-Δ200*                                                This study
  SL1904          *MAT**a** apm3-Δ::HIS3 leu2 ura3-52 trp1 ade2-101 his3-Δ200*                                   This study
  SL1922          *MATα apm3-Δ::HIS3 leu2 ura3-52 trp1 ade2-101 his3-Δ200 lys2*                                  This study
  SL2163          *MAT**a** apm3-Δ::HIS3 mts1-1 leu2 ura3-52 trp1 ade2-101 his3-Δ200 lys2* + pDS19               This study
  SL2284          *MATα mts1-1 leu2 ura3-52 trp1 his3-Δ200 ade2-101 lys2*                                        This study
  SL2286          *MAT**a** apm3-Δ::HIS3 mts2-1 leu-2 ura3-52 trp1 ade2-101 his3-Δ200 lys2* + *pDS19*            This study
  SL2385          *MAT**a** apm3-Δ::HIS3 vpt21(vps21) leu2 ura3-52 trp1 his3-Δ200 lys2*                          This study
  SL2531          *MATα apm3-Δ::HIS3 vps1-Δ::LEU2 leu2 ura3-52 trp1 his3-Δ200 CAN1?*                             This study
  SL2611          *MATα apm3-Δ::HIS3 pep12-Δ::TRP1 ura3-52 trp1 HIS3*                                            This study
  SL2755          *MATα apm3-Δ::HIS3 vpl7-1(vps34) leu2 ura3-52 sde6 his4 HIS3? PEP4?*                           This study
  SL2756          *MAT**a** apm3-Δ:HIS3 vpl19-10(vps15) leu2 ura3-52 ade6 his4 HIS3? PEP4?*                      This study
  SL2757          *MAT**a** apm3-Δ::HIS3 vpl21-13(vps19) leu2 ura3-52 trp1 HIS3 PEP4?*                           This study
  SL2758          *MAT**a** apm3-Δ::HIS3 vpl22-7(vps39) leu2 ura3-52 ade6 HIS3 PEP4?*                            This study
  SL2759          *MATα* apm3-Δ::HIS3 vpl31-2(vps9) leu2 ura3-52 ade6 his4 HIS3? PEP4?                           This study
  SL2763          *MATα apm3-Δ::HIS3 sec1-1 leu2 ura3-52*                                                        This study
  SL2764          *MAT**a** apm3-Δ::HIS3 sec4-8 ura3-52 trp1 HIS3*                                               This study
  SL2765          *MATα* apm3-Δ::HIS3 sec6-4 ura3-52 his3-Δ200                                                   This study
  SL2766          *MAT**a** apm3-Δ::HIS3 end3-1 leu2 ura3-52 trp1 his4 bar1-1 HIS3?*                             This study
  SL2767          *MAT**a** apm3-Δ::HIS3 end4-1 leu2 ura3-52 trp1 his4 bar1-1 HIS3?*                             This study
  SL2820          *MATα apm3-Δ::HIS3 vpl25-6(vps33) leu2 ura3-52 trp1 ade6 HIS3? PEP4?*                          This study
  SL2821          *MATα apm3-Δ::HIS3 pep3-Δ::LEU2 leu2 ura3-52 trp1 his1 HIS3?*                                  This study
  SL2822          *MATα apm3-Δ::HIS3 pep5-Δ::URA3 leu2 ura3-52 trp1 HIS3?*                                       This study
  SL2845          *MATα apm3-Δ::HIS3 vpl4-1(vps4) leu2 ura3-52 his4 pep4-3 HIS3?*                                This study
  SL2846          *MATα apm3-Δ::HIS3 vpt4(vps26) leu2 ura3-52 trp1 his3*                                         This study
  SL2850          *MATα apm3-Δ*::HIS3 vps27-Δ::LEU2 leu2 ura3-52 trp1 his3                                       This study
  SL2864          *MATα apm3-Δ::HIS3 ypt7-Δ::URA3 leu2 ura3-52 trp1 HIS3?*                                       This study
  SL2951          *MATα apm3-Δ::HIS3 pep4::HIS3 prb1-Δ1.6R CAN1 leu2 ura3-52 trp1 HIS3*                          This study
  SL2955          *MAT**a** apm3-Δ::HIS3 vps45-13 leu2 ura3-52 trp1 his3-Δ200 ade2*                              This study
  SL2956          *MAT**a** apm3-Δ::HIS3 vps45-13 leu2 ura3-52 trp1 his3-Δ200 ade2*                              This study
  SL3034          *MAT**a** apm3-Δ::HIS3 vat2-Δ::LEU2 leu2 ura3-52 his3 CAN1?*                                   This study
  SL3037          *MAT**a** apm3-Δ::HIS3 vps8-Δ::URA3 leu2 ura3-52 trp1 his3*                                    This study
  SL3089          *MAT**a** apm3-Δ::HIS3 vps45-Δ leu2 ura3-52 his4 HIS3?*                                        This study
  SL3129          *MAT**a** apm3-Δ::HIS3 mts1-1 leu2 ura3-52 trp1 his3-Δ200*                                     This study
  SL3130          *MAT**a** apm3-Δ::HIS3 vps35-Δ::HIS3 leu2 ura3-52 trp1 his3 SUC2?*                             This study
  HPY20           *MAT**a** ap15::HIS3 leu2 ura3-52 his3*                                                        [@B35]
  LRB858          *MAT**a** ap16::URA3 leu2 ura3-52 his3*                                                        [@B35]
  LRB739          *MAT**a** aps 3::LEU2 leu2 ura3-52 his3*                                                       [@B35]
  SF838-1D        *MATα vp14-1(vps4) leu2 ura3-52 his4 ade6 pep4-3*                                              T. Stevens
  SNY17           *MATα pho8-Δ::LEU2 leu2 ura3-52 his3-Δ200 trp1-Δ901 lys2-801*                                  S. Nothwehr

 

![Precursor CPY is secreted from *mts1-1* cells. Cells were pulse labeled with \[^35^S\]methionine and \[^35^S\]cysteine for 10 min and then chased for 30 min with excess cold amino acids. CPY was then immunoprecipitated from internal (*I*) and external (*E*) fractions. Strains indicated are: *wt*, SL1652 + pDS24 (p*APM3*, *CEN*); *apm3-Δ*, SL1652; *mts1-1*, SL2284; *mts2-1*, SL2286. *p2CPY* indicates precursor CPY; *mCPY* indicates mature CPY.](JCB.14674f1){#F1}

![Proposed sorting steps blocked by *vps* and other trafficking mutants analyzed in Table [II](#TII){ref-type="table"}. The sorting steps shown and the placement and grouping of mutants are based on a large number of studies ([@B43]; [@B55], and citations therein). In the Vps pathway cargo molecules are sorted at the late Golgi/TGN into transport vesicles that fuse with a PVC/ endosomal compartment. This latter step is blocked in many of the original class D *vps* mutants, such as *vps45.* Exit from the PVC for transport to the vacuole and for recycling back to the Golgi is thought to require the function of the class E mutants. Class C *vps* mutants block the final step of transport to the vacuole. Some of the sorting mutants analyzed in Table [II](#TII){ref-type="table"} are indicated with a question mark or are not shown in the figure (*vps8*, *vps39*, *pep8*, and *dnm1*). In these cases the placement in the sorting pathways is more ambiguous. Mutants showing synthetic growth phenotypes with *apm3-Δ* are indicated with an *asterisk.*](JCB.14674f2){#F2}

###### 

Genetic Interactions of apm3-Δ with Vesicle Transport Mutants[\*](#TFII-150){ref-type="table-fn"}

  *vps* class               Genotype                           *vps* allele       Growth at 25° or 30°C      Growth at 34° or 37°C
  ---------------------- -- ------------------------------- -- --------------- -- ----------------------- -- -----------------------
  *vps* mutants                                                                                              
   A/D                      *vps8 APM3*                        *Δ*                ++                         ++
                            *vps8 apm3-Δ*                      *Δ*                ++                         ++
   A                        *vps35 APM3*                       *Δ*                ++                         ++
                            *vps35 apm3-Δ*                     *Δ*                ++                         ++
   B                        *vam6 (vps39) APM3*                *vpl18-9*          ++                         ++
                            *vam6 (vps39) apm3-Δ*              *vpl18-9*          ++                         ++
   B                        *ypt7 APM3*                        *Δ*                ++                         ++
                            *ypt7 apm3-Δ*                      *Δ*                ++                         ++
   C                        *pep5 (vps11, end1) APM3*          *Δ*                ++                         ±
                            *pep5 (vps11, end1) apm3-Δ*        *Δ*                ++                         ±
   C                        *pep3 (vps18) APM3*                *Δ*                ++                         \+
                            *pep3 (vps18) apm3-Δ*              *Δ*                ++                         \+
   C                        *vps33 (pep14, slp1) APM3*         *vp125-6*          ++                         \+
                            *vps33 (pep14, slp1) apm3-Δ*       *vpl25-6*          ++                         ±
   D                        *vps3 (pep6) APM3*                 *vpl3-1*           ++                         ++
                            *vps3 (pep6) apm3-Δ*               *vpl3-1*           ++                         −
   D                        *pep12 (vps6) APM3*                *Δ*                ++                         ++
                            *pep12 (vps6) apm3-Δ*              *Δ*                ++                         −
   D                        *vps9 APM3*                        *vpl31-2*          ++                         ++
                            *vps9 apm3-Δ*                      *vpl31-2*          ++                         \+
   D                        *vps15 APM3*                       *vpl19-10*         ++                         ++
                            *vps15 apm3-Δ*                     *vpl19-10*         ++                         ±
   D                        *pep7 (vps19) APM3*                *Δ*                ++                         ++
                            *pep7 (vps19) apm3-Δ*              *Δ*                ++                         ±
   D                        *vps21 APM3*                       *vpt21*            ++                         ++
                            *vps21 apm3-Δ*                     *vpt21*            ++                         −
   D                        *vps34 (pep15, end12) APM3*        *vpl7-1*           ++                         \+
                            *vps34 (pep15, end12) apm3-Δ*      *vpl7-1*           ++                         \+
   D                        *vps45 APM3*                       *Δ*                ++                         ++
                            *vps45 apm3-Δ*                     *Δ*                ++                         −
   D                        *vps45 APM3*                       *mts1-1*           ++                         ±
                            *vps45 apm3-Δ*                     *mts1-1*           ±                          −
   D                        *vps45 APM3*                       *vps45-13*         ++                         ++
                            *vps45 apm3-Δ*                     *vps45-13*         ++                         ++
   E                        *vps4 (end13) APM3*                *vpl4-1*           ++                         ++
                            *vps4 (end13) apm3-Δ*              *vpl4-1*           ++                         ++
   E                        *vps27 APM3*                       *Δ*                ++                         ++
                            *vps27 apm3-Δ*                     *Δ*                ++                         ++
   F                        *vps1 APM3*                        *Δ*                ++                         \+
                            *vps1 apm3-Δ*                      *Δ*                \+                         ±
   F                        *pep8 (vps26) APM3*                *vpt4*             ++                         ++
                            *pep8 (vps26) apm3-Δ*              *vpt4*             ++                         ++
                                  Genotype                     Mutant allele      Growth at 25° or 30°C      Growth at 34° or 37°C
  Other mutants tested                                                                                       
                            *sec1 APM3*                        *sec1-1*           ++                         ±
                            *sec1 apm3-Δ*                      *sec1-1*           ++                         ±
                            *sec4 APM3*                        *sec4-8*           ++                         −
                            *sec4 apm3-Δ*                      *sec4-8*           ++                         −
                            *sec6 APM3*                        *sec6-4*           ++                         ±
                            *sec6 apm3-Δ*                      *sec6-4*           ++                         ±
                            *dnm1 APM3*                        *Δ*                ++                         ++
                            *dnm1 apm3-Δ*                      *Δ*                ++                         ++
                            *end3 APM3*                        *end3-1*           ++                         ++
                            *end3 apm3-Δ*                      *end3-1*           ++                         −
                            *end4 APM3*                        *end4-1*           ++                         ±
                            *end4 apm3-Δ*                      *end4-1*           ++                         −
                            *vac8 APM3*                        *Δ*                ++                         ++
                            *vac8 apm3-Δ*                      *Δ*                ++                         ++
                            *vma2 (vat2) APM3*                 *Δ*                ++                         ++
                            *vma2 (vat2) apm3-Δ*               *Δ*                ++                         ++

Isogenic pairs of strains were generated by transforming the indicated double mutants with an *APM3* plasmid. For simplicity, *apm3-Δ* strains complemented with p*APM3* are shown as *APM3* genotype. In the crosses of *apm3-Δ* to *vac8-Δ* and *dnm1-Δ* isogenic pairs were not made, but all spores from crosses (±*apm3-Δ*) grew normally at all temperatures tested. Growth of strains was scored at 25°, 30°, 34°, and 37°C. The score shown is for the temperature under which the observed differences ±*APM3* was greatest, or if no difference was seen, at the highest temperature that allowed growth. For example, for some strains the strongest synthetic interaction was observed at 34°C, but at 37° both strains were completely inviable, since the nonpermissive temperature for the vesicle transport mutant had been reached. Scores are designated: ++, *wt* growth; +, poor growth; ±, very poor growth; −, dead/no growth.  

![ALP processing is defective in AP-3 mutant cells. (*A*) Pulse-chase immunoprecipitation of ALP from isogenic *wt* (SL1652 + pDS24 \[p*APM3*, *CEN*\]) and *apm3-Δ* (SL1652) cells. Cells were labeled with \[^35^S\]methionine and \[^35^S\]cysteine for 10 min, chased for indicated times (min), and subjected to IP with ALP antiserum. (*B*) Steady state levels of ALP forms in cells of the indicated genotypes (*wt*, SL1463; *pho8-Δ*, SNY17; *aps3-Δ*, LRB739; *apm3-Δ*, SL1652; *apl5-Δ*, HPY20; *apl6-Δ*, LRB858). Cells were lysed and prepared for immunoblotting with affinity-purified ALP antibodies. *pALP*, precursor ALP; *mALP*, mature ALP; *\*ALP*, soluble lumenal ALP are indicated.](JCB.14674f3){#F3}

![Fractionation of ALP forms in AP-3 mutant cells. Cells from an isogenic pair of strains (*wt*, SL1652 + pDS24 \[p*APM3*, *CEN*\]; *apm3-Δ*, SL1652) were subjected to subcellular fractionation, followed by immunoblot analysis with anti-ALP antibodies. ALP forms are as indicated in Fig. [3](#F3){ref-type="fig"}. *S13K*, 13,000 *g* supernatant; *S100K*, 100,000 *g* supernatant; *P100K*, 100,000 *g* pellet.](JCB.14674f4){#F4}

![Immunofluorescence localization of ALP in AP-3 mutant cells. *wt* (SL1653 + pDS24 \[p*APM3*, *CEN*\]) and *apm3-Δ* (SL1653) cells were prepared for immunofluorescence. The V-ATPase was detected with monoclonal antibody 13D11 and goat anti--mouse Cy3. ALP was visualized with affinity-purified ALP antibodies and goat anti--rabbit FITC secondary.](JCB.14674f5){#F5}

###### 

Loss of AP-3 function results in disappearance of the class E PVC. ALP, V-ATPase, and Kex2p were localized by immunofluorescence as described in Figs. [5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"}. (*A*) Localization of ALP and the V-ATPase in the class E prevacuole in *vps4* strain, SF838-1D. (*B*) *vps4* (SF838-1D + YCpKX22) cells stained for Kex2p and the V-ATPase. (*C*) Localization of ALP and the V-ATPase in the *vps4 apm3-Δ* strain, SL2845. (*D*) Colocalization of Kex2p and the V-ATPase to the vacuole in *vps4 apm3-Δ* cells (SL2845 + YCpKX22).

![](JCB.14674f8a)

![](JCB.14674f8c)

![Golgi staining is normal in AP-3 mutant cells. *wt* (SL1463 + YCpKX22) and *apm3-Δ* (SL1652 + YCpKX22) cells were stained with affinity-purified Kex2p antibodies followed by goat anti--rabbit FITC secondary. The plasmid YCpKX22 was used for overexpression of Kex2p to enable intracellular visualization as described previously ([@B67]).](JCB.14674f6){#F6}

![ALP reaches the vacuole via the Vps Pathway in AP-3 mutant cells. Isogenic pairs of strains were shifted to 37°C for 30 min, pulse labeled for 10 min, chased for the indicated times (min), and then subjected to IP with ALP antiserum. (*A*) *apm3-Δ* (SL2767 + p*END4*, *CEN*) and *apm3-Δ end4-1* (SL2767). (*B*) *apm3-Δ* (SL1904) and *apm3-Δ vps45-13* (SL2956).](JCB.14674f7){#F7}

![Models for the Vps-dependent and alternative ALP pathways to the vacuole. (*A*) Proteins such as the Vps10p CPY sorting receptor, Kex2p and the vacuolar ATPase membrane protein, Vph1p, exit the late Golgi in transport vesicles, which then fuse with the prevacuole. This fusion is dependent upon the class D Vps proteins, such as Vps45p. In a step dependent upon the class E Vps proteins (e.g., Vps4p), late Golgi proteins and Vps10p are recycled to the Golgi from the PVC, whereas resident vacuolar proteins, such as Vph1p and soluble vacuolar hydrolases continue onto the vacuole in a step dependent on late acting Vps proteins (e.g., Vps33p and Vam3p). As shown in this study, ALP transport through the alternative route to the vacuole is dependent upon AP-3 function. It is not clear how many intermediate steps are required for transport of ALP to the vacuole and at what step AP-3 actually functions. Shown here is the possibility that AP-3 is involved in cargo selection at the late Golgi and that Vps41p/Vam2p acts at second, later step in the ALP pathway. Final delivery of ALP to the vacuole is also dependent on the Vps33p and Vam3p. The vacuolar t-SNARE, Vam3p, may also transit the alternative ALP pathway to the vacuole. (*B*) Much of the existing information on transport of cargo molecules to the vacuole is consistent with a model in which the Vps prevacuole identified in class E mutants is an early endosomal compartment that intersects with endocytic traffic. In this case, convergence of the alternative ALP and Vps pathways would occur at a late endosome. The final delivery of constituents from both the Vps and ALP pathways would still be dependent upon the class C and other late acting Vps components. The possibility that AP-3 is involved in recycling from an endosomal compartment back to the Golgi is also indicated in this model (see Discussion).](JCB.14674f9){#F9}
